Prevalence and disease burden of peripheral neuropathy in the general population in Mexico city: a cross-sectional epidemiological study

References

• Nold CS, Nozaki K. Peripheral neuropathy: clinical pearls for making the diagnosis. JAAPA. 2020;33(1):9–15. doi: 10.1097/01.JAA.0000615460.45150.e0.
   PubMedGoogle Scholar
• Sommer C, Geber C, Young P, et al. Polyneuropathies. Dtsch Arztebl Int. 2018;115:83–90.
   PubMed Web of Science ®Google Scholar
• Watson JC, Dyck PJB. Peripheral neuropathy: a practical approach to diagnosis and symptom management. Mayo Clin Proc. 2015;90(7):940–951. doi: 10.1016/j.mayocp.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314(20):2172–2181. doi: 10.1001/jama.2015.13611.
   PubMed Web of Science ®Google Scholar
• Jones MR, Urits I, Wolf J, et al. Drug-Induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol. 2020;15:38–48.
   PubMed Web of Science ®Google Scholar
• Landmann G. Diagnostik und therapie der schmerzhaften polyneuropathie. Psychiatr Neurol. 2012;5:13–16.
   Google Scholar
• Lehmann HC, Wunderlich G, Fink GR, et al. Diagnosis of peripheral neuropathy. Neurol Res Pract. 2020;2(1):20. doi: 10.1186/s42466-020-00064-2.
   PubMedGoogle Scholar
• Hakim M, Kurniani N, Pinzon RT, et al. Improvement of quality of life in patients with peripheral neuropathy treated with a fixed dose combination of high-dose vitamin B1, B6 and B12: results from a 12-week prospective non-interventional study in Indonesia. J Clin Trials. 2018;2:1000343.
   Google Scholar
• Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35(3):206–213. doi: 10.1016/j.diabet.2008.11.004.
   PubMed Web of Science ®Google Scholar
• Riandini T, Wee HL, Khoo EYH, et al. Functional status mediates the association between peripheral neuropathy and health-related quality of life in individuals with diabetes. Acta Diabetol. 2018;55(2):155–164. doi: 10.1007/s00592-017-1077-8.
   PubMed Web of Science ®Google Scholar
• Yang C-J, Hsu H-Y, Lu C-H, et al. Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality? J Diabetes Investig. 2018;9(1):179–185. doi: 10.1111/jdi.12649.
   PubMed Web of Science ®Google Scholar
• Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, et al. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011;6:260–273.
   PubMedGoogle Scholar
• Malik RA, Andag-Silva A, Dejthevaporn C, et al. Diagnosing peripheral neuropathy in South-East Asia: a focus on diabetic neuropathy. J Diabetes Investig. 2020;11(5):1097–1103. doi: 10.1111/jdi.13269.
   PubMed Web of Science ®Google Scholar
• Hicks CW, Wang D, Daya N, et al. The association of peripheral neuropathy detected by monofilament testing with risk of falls and fractures in older adults. J Am Geriatr Soc. 2023;71(6):1902–1909. doi: 10.1111/jgs.18338.
   PubMed Web of Science ®Google Scholar
• Carmichael J, Fadavi H, Ishibashi F, et al. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol. 2021;12:671257. doi: 10.3389/fendo.2021.671257.
   PubMed Web of Science ®Google Scholar
• Hakim M, Kurniani N, Pinzon R, et al. A review on prevalence and causes of peripheral neuropathy and treatment of different etiologic subgroups with neurotropic B vitamins. J Clin Exp Pharmacol. 2019;9(4):262. doi: 10.35248/2161-1459.19.9.262.
   Google Scholar
• Brown JJ, Pribesh SL, Baskette KG, et al. A comparison of screening tools for the early detection of peripheral neuropathy in adults with and without type 2 diabetes. J Diabetes Res. 2017;2017:1467213. doi: 10.1155/2017/1467213.
   PubMed Web of Science ®Google Scholar
• Malik RA, Aldinc E, Chan S-P, et al. Perceptions of painful diabetic peripheral neuropathy in South-east asia: results from patient and physician surveys. Adv Ther. 2017;34(6):1426–1437. doi: 10.1007/s12325-017-0536-5.
   PubMed Web of Science ®Google Scholar
• Bongaerts BWC, Rathmann W, Heier M, et al. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study. Diabetes Care. 2013;36(5):1141–1146. doi: 10.2337/dc12-0744.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27(7):629–638. doi: 10.1002/dmrr.1225.
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Elhadd T, Chinnaiyan S, et al. Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar. J Diabetes Investig. 2021;12(4):592–600. doi: 10.1111/jdi.13388.
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Elhadd T, Chinnaiyan S, et al. Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar. J Diabetes Investig. 2019;10(6):1558–1564. doi: 10.1111/jdi.13037.
   PubMed Web of Science ®Google Scholar
• Ziegler D, Landgraf R, Lobmann R, et al. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Diabetes Res Clin Pract. 2018;139:147–154. doi: 10.1016/j.diabres.2018.02.043.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.
   Google Scholar
• Malik RA. Wherefore art thou, O treatment for diabetic neuropathy? Int Rev Neurobiol. 2016;127:287–317. doi: 10.1016/bs.irn.2016.03.008.
   PubMed Web of Science ®Google Scholar
• Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19(10):86. doi: 10.1007/s11892-019-1212-8.
   PubMed Web of Science ®Google Scholar
• Lim JZM, Burgess J, Ooi CG, et al. The peripheral neuropathy prevalence and characteristics are comparable in people with obesity and long-duration type 1 diabetes. Adv Ther. 2022;39(9):4218–4229. doi: 10.1007/s12325-022-02208-z.
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Gao L, Li Y, et al. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol. 2018;5(4):397–405. doi: 10.1002/acn3.531.
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Xia R, Banerjee M, et al. Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status. Diabetes Care. 2016;39(5):801–807. doi: 10.2337/dc16-0081.
   PubMed Web of Science ®Google Scholar
• World Obesity Federation. World obesity atlas. 2023. [accessed May 2024]. https://data.worldobesity.org/publications?cat=19.
   Google Scholar
• Cascio MA, Mukhdomi T. Small fiber neuropathy. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• National Institute of Neurological Disorders and Stroke. Peripheral neuropathy fact sheet. 2018 [accessed 2024 May]. https://www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy.
   Google Scholar
• Hicks CW, Wang D, Windham BG, et al. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep. 2021;11(1):19159. doi: 10.1038/s41598-021-98565-w.
   PubMed Web of Science ®Google Scholar
• Trivedi S, Pandit A, Ganguly G, et al. Epidemiology of peripheral neuropathy: an Indian perspective. Ann Indian Acad Neurol. 2017;20(3):173–184. doi: 10.4103/aian.AIAN_470_16.
   PubMed Web of Science ®Google Scholar
• Castrejón-Pérez RC, Aguilar-Salinas CA, Gutiérrez-Robledo LM, et al. Frailty, diabetes, and the convergence of chronic disease in an age-related condition: a population-based nationwide cross-sectional analysis of the mexican nutrition and health survey. Aging Clin Exp Res. 2018;30(8):935–941. doi: 10.1007/s40520-017-0852-2.
   PubMed Web of Science ®Google Scholar
• Herman WH, Pop-Busui R, Braffett BH, et al. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications. Diabet Med. 2012;29(7):937–944. doi: 10.1111/j.1464-5491.2012.03644.x.
   PubMed Web of Science ®Google Scholar
• Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17(11):1281–1289. doi: 10.2337/diacare.17.11.1281.
   PubMed Web of Science ®Google Scholar
• Bennedsgaard K, Grosen K, Attal N, et al. Neuropathy and pain after breast cancer treatment: a prospective observational study. Scand J Pain. 2023;23(1):49–58. doi: 10.1515/sjpain-2022-0017.
   PubMed Web of Science ®Google Scholar
• Dias LS, Nienov OH, Machado FD, et al. Polyneuropathy in severely obese women without diabetes: prevalence and associated factors. Obes Surg. 2019;29(3):953–957. doi: 10.1007/s11695-018-03627-0.
   PubMed Web of Science ®Google Scholar
• Mete T, Aydin Y, Saka M, et al. Comparison of efficiencies of Michigan neuropathy screening instrument, neurothesiometer, and electromyography for diagnosis of diabetic neuropathy. Int J Endocrinol. 2013;2013:821745–821747. doi: 10.1155/2013/821745.
   PubMed Web of Science ®Google Scholar
• Bastyr EJ, Price KL, Bril V. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther. 2005;27(8):1278–1294. doi: 10.1016/j.clinthera.2005.08.002.
   PubMed Web of Science ®Google Scholar
• Moors VJ, Graveran KD, Shahsavari D, et al. A cross-sectional study describing peripheral neuropathy in patients with symptoms of gastroparesis: associations with etiology, gastrointestinal symptoms, and gastric emptying. BMC Gastroenterol. 2022;22(1):315. doi: 10.1186/s12876-022-02372-0.
   PubMed Web of Science ®Google Scholar
• Scarpato S, Galassi G, Monti G, et al. Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach. Clin Exp Rheumatol. 2020;38:1231–1237.
   PubMed Web of Science ®Google Scholar
• Ahmed MA, Muntingh G, Rheeder P. Vitamin B12 deficiency in metformin-treated type-2 diabetes patients, prevalence and association with peripheral neuropathy. BMC Pharmacol Toxicol. 2016;17(1):44. doi: 10.1186/s40360-016-0088-3.
   PubMedGoogle Scholar
• Vinik AI, Bril V, Kempler P, et al. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther. 2005;27(8):1164–1180. doi: 10.1016/j.clinthera.2005.08.001.
   PubMed Web of Science ®Google Scholar
• Ibarra CT, Rocha J de J, Hernández R, et al. Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención. Rev Med Chil. 2012;140:1126–1131.
   PubMedGoogle Scholar
• Jiménez Victoria MA. Incidencia de neuropatía diabética con el test de Michigan en la UMF 61. 2015;
   Google Scholar
• Freeman R, Gonzalez-Duarte A, Barroso F, et al. Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages. Ann Clin Transl Neurol. 2022;9(9):1370–1383. doi: 10.1002/acn3.51636.
   PubMed Web of Science ®Google Scholar
• Ticse R, Pimentel R, Mazzeti P, et al. Elevada frecuencia de neuropatía periférica en pacientes con diabetes mellitus tipo 2 de un hospital general de Lima-Perú. Rev Med Hered. 2013;24(2):114–121. doi: 10.20453/rmh.v24i2.593.
   Google Scholar
• Ware JEJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. doi: 10.1097/00005650-199206000-00002.
   PubMed Web of Science ®Google Scholar
• García JJG. Muestreo y cálculo de tamaño de muestra. Epidemiol Clnica. 2013:292.
   Google Scholar
• Lazzarini PA, Hurn SE, Fernando ME, et al. Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis. BMJ Open. 2015;5(11):e008544. doi: 10.1136/bmjopen-2015-008544.
   PubMed Web of Science ®Google Scholar
• van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662. doi: 10.1016/j.pain.2013.11.013.
   PubMed Web of Science ®Google Scholar
• Pradilla Ardila G, Vesga Angarita BE, León-Sarmiento FE. Study of neurological diseases prevalence in Aratoca, a rural area of Eastern Colombia. Rev Med Chil. 2002;130(2):191–199.
   PubMed Web of Science ®Google Scholar
• Yovera-Aldana M, Velásquez-Rimachi V, Huerta-Rosario A, et al. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: a systematic review and meta-analysis. PLOS One. 2021;16(5):e0251642. doi: 10.1371/journal.pone.0251642.
   PubMed Web of Science ®Google Scholar
• Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population > =40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27(7):1591–1597. doi: 10.2337/diacare.27.7.1591.
   PubMed Web of Science ®Google Scholar
• Liu X, Xu Y, An M, et al. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLOS One. 2019;14(2):e0212574. doi: 10.1371/journal.pone.0212574.
   PubMed Web of Science ®Google Scholar
• Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62(4):310–318. doi: 10.1136/jnnp.62.4.310.
   PubMed Web of Science ®Google Scholar
• Suzuki M. Peripheral neuropathy in the elderly. Handb Clin Neurol. 2013;115:803–813. doi: 10.1016/B978-0-444-52902-2.00046-1.
   PubMedGoogle Scholar
• Nix WA. Muscles, nerves, and pain. Boston: Springer; 2017.
   Google Scholar
• Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care. 2004;27(6):1458–1486. doi: 10.2337/diacare.27.6.1458.
   PubMed Web of Science ®Google Scholar
• Hawke SH, Davies L, Pamphlett R, et al. Vasculitic neuropathy. A clinical and pathological study. Brain. 1991;114(5):2175–2190. doi: 10.1093/brain/114.5.2175.
   PubMedGoogle Scholar
• Srinivasan A, Paranjothi S, Bhattacharyya K, et al. Consensus recommendation for the management of peripheral neuropathy in India. J Indian Med Assoc. 2018;116:45–55.
   Google Scholar
• Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76(20):1758–1765. doi: 10.1212/WNL.0b013e3182166ebe.
   PubMed Web of Science ®Google Scholar
• Head KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev. 2006;11(4):294–329.
   PubMedGoogle Scholar
• Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care. 2017;40(1):136–154. doi: 10.2337/dc16-2042.
   PubMed Web of Science ®Google Scholar
• World Obesity Federation. https://data.worldobesity.org/.
   Google Scholar